All Research
- 2 mins to read
Cluster headache is associated with significant health and social challenges that necessitate a detailed understanding of long-term patient outcomes to optimize clinical care. In a study published in Cephalalgia, titled “Cluster headache and comorbidities, income and education: A nationwide registry-based matched cohort study,” Møen and colleagues investigated the evolving relationship between this condition, various comorbid pathologies, and the socioeconomic status of affected individuals over a 14 year period.
- 2 mins to read
Cluster headache is defined by its rigid adherence to biological timing, manifesting with almost mathematical precision across days and seasons. In a study published in Sapienza Università di Roma, titled “Circadian Features and Sleep Parameters in an Italian Population of Patients with Cluster Headache,” Giuliani and colleagues investigated the interplay between internal chronotypes and the clinical expression of this condition. By isolating a single geographical population, the researchers aimed to control for environmental variables to better understand the endogenous mechanisms of the disease. These findings offer a deeper look into the biological clock’s role in this "suicide headache."
- 2 mins to read
Primary headache syndromes and sleep disturbances represent a substantial global health burden, with headaches affecting approximately 40% of the population and serving as a leading neurological diagnosis. In a study published in Clocks & Sleep, titled “Mechanistic Overlaps Between Sleep and Headache Disorders: From Dopaminergic Dysfunction to Neuroinflammation—A Narrative Review,” Miller Martinez and colleagues investigated the shared biological foundations that suggest these conditions are deeply interconnected rather than merely coincidental.
- 2 mins to read
Migraine represents a significant global socio-economic burden, affecting around 14% of the population and ranking among the top causes of years lived with disability. Historically, management has been limited to reactive symptom suppression, but a strategic shift is now investigating the microbiome-gut-brain axis as a modifiable, upstream pathway for treatment. In a study published in Nutrients, titled “Migraine and the Gut-Brain Axis-The Role of Microbiome-Targeted Biotics,” Márk Kozák and colleagues investigated how biological modulation of the gut environment could redefine therapeutic outcomes. By pivoting from traditional pharmacology to the regulation of systemic pathways, this research evaluates how biotics may address
- 2 mins to read
In a study published in Arch Neuropsychiatry, titled “Effectiveness of Combined Peripheral Nerve Blocks Versus Isolated Greater Occipital Nerve Block in the Management of Cluster Headache,” Yön and colleagues investigated the clinical utility of multi-point interventional strategies for one of the most severe primary headache disorders. The research addresses the critical need for alternative therapies in patients who do not find relief through standard pharmacological protocols.
- 3 mins to read
Improving the safety profiles of surgical neuromodulation is a critical strategic imperative for increasing patient adoption and bolstering payer confidence. When technical complications such as hardware failure and the necessity for revision surgeries are minimized, clinicians can present a more stable, cost-effective value proposition for chronic pain interventions. This shift from experimental perception to reliable clinical standard is essential for the long-term integration of neurostimulation into the standard of care. Refractory chronic cluster headaches (rCCH) are widely regarded as one of the most agonizing conditions known to medical science, often driving patients to extreme despair. In a study published in
- 2 mins to read
Historically, clinical assumptions regarding Asian populations suggested that cluster headaches were an exceptionally rare occurrence, a misconception that obscured the true burden of the disease. In a study published in 日本頭痛学会誌 (Journal of the Japanese Headache Society), titled “New Insights from the Korean Cluster Headache Registry: Multicenter Findings on Epidemiology, Comorbidity, and Treatment,” Cho and colleagues investigated the validity of these long held perceptions using expansive registry data. The results highlight a sharp tension between older retrospective estimates and the higher prevalence uncovered through systematic prospective observation. This evolution in understanding reveals a critical need to examine the specific clinical
- 3 mins to read
The evolution of neurological pain management is increasingly defined by a shift from broad-spectrum symptom management to targeted, mechanism-based interventions. Cluster headache (CH) represents one of the most agonizing and life-altering conditions in clinical neurology, characterized by a level of pain that frequently exceeds the efficacy of standard care. In a study published in BMC Neurology, titled “Safety and efficacy of calcitonin gene-related peptide antagonists for cluster headache: a systematic review and meta-analysis,” Khanfar and colleagues investigated the clinical performance of therapies targeting the calcitonin gene-related peptide pathway. This comprehensive analysis evaluates whether these novel biologics can provide the preventive
- 3 mins to read
The strategic challenge of managing cluster headaches is rooted in their profound intensity and the clinical frequency with which they resist standard pharmacological protocols. For patients who fail to respond to traditional preventive or acute medications, identifying alternative interventions is a matter of urgent clinical necessity. In a study published in Research Square, titled “Neuromodulation in the Management of Cluster Headaches: a Systematic Review and Meta-Analysis,” Badahah and colleagues investigated the efficacy and safety of diverse electrical and magnetic stimulation techniques. This analysis addresses a vital need to identify treatments that can bridge the gap for those left behind by
- 3 mins to read
Cluster headache (CH) is a rare but excruciating primary headache disorder characterized by unilateral, severe attacks that impose a profound disability and high socioeconomic burden on those affected. For the subset of patients who fail primary medical management, investigating non-invasive alternatives is a strategic priority to reduce the risk of suicidality and improve daily functioning. In a study published in Neurosurgical Review, titled “Stereotactic radiosurgery in the management of cluster headache: evidence from a systematic review and meta-analysis,” Hajikarimloo and colleagues investigated the efficacy and safety of stereotactic radiosurgery (SRS) as a treatment for patients with medically refractory cluster headache.
Join the Community
Subscribe to receive updates on new research findings, articles and inspired conversations.
We respect your privacy. Unsubscribe at any time.